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This review makes an attempt to combine the insig ts 
gained into the biochemistry and physiology f bile acids 
with the elegant supramolecular systems designed from 
them. Bile acids are cholesterol-derived facial amphi-
philes responsible for the solubilization of cholesterol 
and fat through mixed micelle formation with phospho-
lipids. An intriguing aspect of bile acids is that their 
chemical structure has been postulated to correlate with 
vertebrate evolution. However, the etiology of molecular 
evolution of bile acids is still poorly understood. There 
has been a steady progress in the studies aimed at elu-
cidating physiological functions and developing pharma-
cological applications of bile acids. In recent years, bile 
acids and their analogues have been extensively utilized 
as supramolecular receptors for various types of guest 
molecules and ions. Under certain defined conditions, the 
supramolecular association of bile acids and their deri-
vatives leads to gel formation. Thus, modified bile acids 
might find use in the design of futuristic materials. 
 
DESPITE having a history of more than a century, bile-acid 
science (cholanology) continues to have importance in bio-
logy and medicine1–3. Bile salts are steroidal detergen s, which 
together with lipids/fats/cholesterol form mixed micelles 
in the intestine to enable fat digestion and absorption 
through the intestinal wall1. They are biosynthesized from 
cholesterol in the liver and stored in the gall bladder 
(Figure 1). Bile is secreted through the bile duct into the 
intestine when food passes from the stomach to the duode-
num. Most of the bile salts secreted into the upper region 
of the small intestine are absorbed along with dietary lipids 
at the lower end of the small intestine. They are separated 
from the dietary lipid and returned (more than 85%) to the 
liver for re-circulation. This movement of bile salts is ter-
med as enterohepatic circulation (Figure 1 b). The most abun-
dant bile salts in humans are cholate, chenodeoxycholat  
and deoxycholate, and they are normally conjugated with 
either glycine (75%) or taurine (25%). Conjugation increases 
the aqueous solubility of bile salts under physiological 
conditions. The chemical structures of free and conjugated 
cholic acid (taurocholate and glycolate) are discuss d later 
in the article. All primary bile acids appear to have three 
features in common: (i) they are the major end-products of 
cholesterol metabolism, (ii) they are secret d into the bile 
largely in a conjugated form, and (iii) these conjugates are 
membrane-impermeable, water-soluble, amphi ilic mole-
cules having a powerful ability to transform lamellar arrays 
of lipids into mixed micelles1,2. 
Historical perspectives 
Studies on the chemistry of compounds present in the bile 
had begun in the early nineteenth century3. Remarkable 
experiments performed by Thenard and Berzelius led to 
the identification f choleic acid and bilin4. The isolation 
of nitrogen-free bile acid (cholic acid) was achieved by 
Demarcay4. A crystalline sample of a bile acid was first 
prepared by Platner5, but any structural insight was not 
possible at that time. However, painstaking efforts were 
taken by chemists, Strecker and Mylius to work out the 
molecular formulae of bile acids (both free and conjugated 
forms)6. Wieland and Sorage7 first demonstrated the forma-
tion of cholic acid–fatty acid complex (choleic acid). 
Wieland and Windaus performed detailed structural studies 
on bile acids8. After Bernal elucidated the cyclopentano-
perhydrophenanthrene structure of cholesterol by X-ray in 
1932, Rosenheim and King were able to propose the correct 
structure of bile acids9. The current scientific phase of 
bile acid research began in the 1950s. Isolation and char-
acterization of bile acids from different species, extensive 
metabolic studies and detailed physico-c emical studies 
were embarked upon during this period. 
Chemical structure of bile acids 
All bile acids consist of two connecting units, a rigid 
ster id nucleus and a short aliphatic side chain (Figure 
2)2. The steroid nucleus of bile acids has the saturated tetra-
cyclic hydrocarbon perhydrocyclopentanophenanthrene, 
containing three six-member rings (A, B and C) and a five-
member ring (D). In addition, there are angular methyl 
groups at positions C-18 and C-19. In higher vertebrates, the 
bile acid nucleus is curved (beaked) because the A and the 
B rings are in a cis-fused configuration. Some bile acids in 
lower vertebrates, known as allo-bile acids, are flat because 
of an A/B trans-fusion (5a-stereochemistry). The side chain 
structure determines the class of the compound (bile acids 
or bile alcohols). There are four different types of bile alco-
hols (C27, C26, C25 and C24) and they occur in the less 
evolved forms of life. There are two major classes of bile 
acids depending on the length of the side chain: C27 and 
C24 bile acids. In higher vertebrates, C24 bile acids consti-
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Figure 1. a, Digestive system; b, Enterohepatic circulation. 
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Figure 2. Structure of cholic acid. a, Chemical structure; b, Perspective structure; c, Cartoon representation (as 
introduced by Small); d, Space-filling model. 
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Figure 3. Structure of conjugated bile acids. , Glycocholic acid;  
b, Taurocholic acid. 
tute a major part of the bile. They are conjugated to glycin  
or taurine to yield the conjugated form of bile acids (Fig-
ure 3). Bile acids are facially amphipathic, i.e. they contain 
both hydrophobic (lipid soluble) and hydrophilic (polar) 
faces. 
Chemical structure of bile acids and evolution 
In contrast to most of the small molecules found in verte-
brates, bile acids are strikingly diverse in a structural sense. 
Bile acids from different species chemically differ in three 
respects: (i) side-chain structure, (ii) stereochemistry of the 
A/B ring fusion, and (iii) the distribution of the number, 
position and stereochemistry of h droxyl groups in the 
steroid nucleus. Several decades ago, Haslewood10 addresse  
the issue of considering the bile acid structure as an aid to 
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the understanding of the evolutionary processes. It has been 
noted that the bile acid structure shows a pattern of pro-
gressive molecular development along the line of vertebrate 
evolution. There is a clear evidence of evolution of bile 
acids through the stages: C27 alcohols ® C27 acids ® C24 
acids. Bile alcohols act as bile salt after conjugation with 
sulphate (which increases water solubility), C27 acids are 
conjugated with taurine and C24 acids exist in the bile as 
taurine and glycine conjugates. It has been suggested that 
the most evolved mam lian bile acids have a 5b-configu-
ration with hydroxyl groups at 3a, 7a and 12a. Names and 
structures of bile acids in vertebrate bile are given in 
Chart 1 (approximately in the descending order of evolution). 
Bile alcohols are not discussed, although they are major 
components in lower vertebrates. 
Biosynthesis of bile acids 
Bile acids are synthesized from cholesterol involving a 
number of complex steps in both the steroid nucleus and the 
side chain (Scheme 1)1,2. This biosynthesis involves at 
least five steps each on the nucleus and the side chain. 
Since these steps may in principle occur in any order, 
elucidation of individual steps of bile acid biosynthesis is 
no  straightforward. In the first step, believed to be the rate-
limiting step, cholesterol is oxidized to 7a-hydroxychole-
sterol by cholesterol 7a-hydroxylase. 7a-Hydroxy cholesterol 
is then converted to the key intermediate cholest-7a-
hydroxy-D4-3-one through the action of an isomerase and 
a reductase. This unsaturated oxo derivative is the branchi g 
point for cholic and chenodoxycholic acid biosynthesis. 
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vii. Oxidative cleavage of side chain 
(C27 acid to C24 acid)  
 
 
Scheme 1. Biosynthesis of bile acids from cholesterol. 
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3a, 7a-Dihydroxycoprostanic acid:  3a, 7a, 12a-Trihydroxycoprostanic acid: 3a, 7a, 12a-Trihydroxycholestanic acid: 
Rattites, alligator, Andean condor Hornbill, alligator, frog Iguana, frog 
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3a, 7a, 16a-Trihydroxycoprost-24-  3a, 7a, 12a-Trihydroxy-25a-coprost-23-enic 3a, 7a, 12a, 24-Tetrahydroxycopro-stanic  
carboxylic acid: Andean condor acid: Toad acid (Varanic acid): Lizard 
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3a, 7a, 12a, 22-Tetrahydroxycoprostanic  3a, 7a, 12a-Trihydroxycoprost-22-ene-24- 23R-hydroxycholic acid: 
acid: Turtle carboxylic acid: Toad Seal, snake 
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Bitocholic acid:  Phocaecholic acid:  1a-Hydrohychenodeoxycholic acid: 
Snake Seal, walrus Australian marsupials 
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Allodeoxycholic acid:  Allocholic acid:  a-Muricholic acid:  
Rabbit Gigi fish Rat 
 
Contd… 
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a-Hyocholic acid:  b-Hyocholic acid (w-Muricholic acid): b-Muricholic acid:  
Pig Rat Rat 
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Pythocholic acid:  Avicholic acid:  Ursodeoxycholic acid:  
Snakes Birds Bear, nutria 
 
 
OH
COOH
OH
 OH
COOH
OH
 OH
COOH
OH
OH
 
 
Deoxycholic acid: Human (bacterial Chenodeoxycholic acid:  Cholic acid:  
7-dehydroxylation product). Human Human 
 
Chart 1. Chemical structure of bile acids in vertebrate bile. 
 
 
Hydroxylation at C-12 leads to the formation of the cholic 
acid backbone. This oxo derivative is then stereoselectively 
reduced to afford the 5b-bile acid skeleton. The second 
key metabolic step, 27-hydroxylation followed by the 
formation of a C27 carboxylic acid, is believed to occur in 
the mitochondrion mediated by a P-450 hydroxylase. Then 
the oxidative cleavage of the side chain (C27 cid to C24 
acid) mediated by peroxisomal enzymes affords the mature 
C24 bile acids. Bile acids are bio-transformed into glycine 
and taurine conjugates by the amidation reaction catalysed 
by an acyltransferase. During the past decade, significant 
developments have been achieved in the genetics of bile 
acid synthesis11. The synthesis of full complement bile acids 
requires the participation of 17 enzymes. The expression 
of selected enzymes is tightly regulated by nuclear hormon 
receptors and other transc iption factors. Mutations in bile-
acid biosynthesis genes responsible for several human dis-
eases involving liver disorder and progressive CNS neuro-
pathy have been identified11. 
Chemical synthesis of rare bile acids 
To the best of our knowledge, the total synthesis of any bile 
acid has not been documented in the litera ure so far12. 
Considerable efforts, however, have been made to obtain 
rare bile acids starting from readily available bile acids, 
enabling one to study the physico-chemical properti s of 
unusual bile acids. Several dec des ago, allo-bile acids 
were obtained by treating the methyl ester of 5b-bile acids 
in boiling p-cymine13. Subsequently, allo-bile acids were 
prepared using different routes involving the D4-3-oxo
derivative as the key intermediate14. Chemical syntheses 
of several rare bile acids (in vertebrates) have been 
achieved by Iida and coworkers15. Stereoselective oxyfun-
cti nalization by dimethyldioxirane has been shown as a 
convenient way of generating new bile acids16. 
 An unusual bile acid, 16a-chenodeoxycholic acid, has 
rec ntly been isolated from certain species of storks and 
herons17. This bile acid was named avicholic acid to signify 
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that, to date, this bile acid has been isolat d only from avian 
species. The first chemical synthesis of avich lic acid was 
achieved by Iida et al.15 from chenodeoxycholic acid using 
stereoselective oxyfunctionalization route. The overall 
yield of avicholic acid was <1%, clearly suggesting th  
need for an improved synthetic route in order to study its 
aggregation behaviour in aqueous media. We developed a 
synthetic route for avicholic acid. It was possible to prepare 
(in 9% overall yield) this rare bile acid from readily available 
chenodeoxycholic acid using Breslow’s biomimetic remote 
functionalization in a key step18. This strategy can possibly be 
extended in order to synthesize other rare bile acids. 
Physiological functions 
Solubilization and transport of lipids 
Bile acids emulsify dietary fat droplets through the forma-
tion of mixed micelles (discussed later in the article). 
This significantly increases the surface area of fat, making 
it available for digestion by lipases, which otherwise cannot 
access the interior of lipid droplets. Bile acids are lipid-
carriers and are able to solubilize many lipids by forming 
mixed micelles with fatty acids, cholesterol and mono-
glycerides. These micelles are responsible for the solubi-
lization and absorption of fat-soluble vitamins19 uch as 
vitamin E. 
Bile salt-activated lipase 
The intestinally located pancreatic enzyme, bile salt-activa-
ted lipase (BAL), possesses unique activities for digesting 
different types of lipids. The reaction scheme for the con-
version of trioleoylglyceride to glycerol catalysed by BAL 
can be described by consecutive first-orde  reactions com-
prising three pseudo-first-order rate constants (k1, k2 and 
k3: Scheme 2). BALs differ from other lipases in their re-
quirement of bile salts for activity. Recently, the crystal 
structures of bovine BAL and its complex with taurocho-
late have been determined at 2.8 Å resolution (Figure 4)20. 
Two bile salt bind ng sites were found in each BAL 
molecule within the BAL–taurocholate complex structure. 
Bile salts activate BAL by binding to a relatively short 
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Scheme 2. Conversion of triglycerides into glycerol catalysed by hu-
man milk BAL. 
10-residue loop near the active site, and stabilize the loop 
in an open conformation. Presumably, this conformational 
change leads to the formation of the subs rate-binding site, 
as suggested from kinetic data.  
Cholesterol homeostasis 
The hepatic synthesis of bile acids accounts for the majority 
of cholesterol breakdown in the body. In humans, every 
day ca. 500 mg of cholesterol is converted to bile acids. 
This route for the elimination of excess cholesterol is pro-
bably important in all animals. It has recently been dis-
covered that bile acids can also act as hormones, which 
bind to nuclear receptors and subsequently modulate the 
expression of proteins involved in cholesterol homeosta-
sis21. A number of nuclear receptors have been shown to 
bind bile acids (cholic and chenodeoxycholic acids), inclu-
ding the farsenoid X receptor (FRX), the LXR-alpha receptor 
nd the CPA receptor. The resulting bile acid–r ceptor 
complexes have been shown to be capa l  of binding to pro-
moter regions of specific genes and either stimulating or 
sup ressing their transcription.  
Pathophysiology of bile acids 
A number of hepato-biliary diseases have been identified 
which are caused by defects in bile acid biosynthesis22. 
The formation of 3b-hydroxy (instead of 3a-hydroxy) bile 
acids was observed in cholestasis2. In some cases, hepato- 
 
 
 
 
Figure 4. Crystal structure of bovine bile salt-activated lipase (dimer) 
showing bound taurocholate molecules (ball and stick, yellow).  
REVIEW ARTICLES 
 
CURRENT SCIENCE, VOL. 87, NO. 12, 25 DECEMBER 2004 1672 
 
OH OH
OH
CH2OH
OH
COOH
Normal
Pathological
 
 
Scheme 3. Mechanism for biosynthesis in CTX disease. 
 
 
 
 
Figure 5. Bacterial swelling agent that in ibits protein synthesis. 
 
 
biliary diseases were associated with a plausible deficiency 
of 12a-hydroxylase. A defect in mitochondrial 27-hydro-
xylation leads to a genetic disease called cerebrotendinous 
xanthomatosis (CTX), which is characterized by progressive 
neurological dysfunction, cataracts, xanthomatosis, etc. 
25-Hydroxylation (instead of 27-hydroxylation) leads to 
disruption in the feedback inhibition of cholesterol bio-
synthesis, which increases the biosynthesis of cholesterol 
and subsequent accumulation of bile alcohols (Scheme 3).  
 Zellweger’s syndrome is associated with defects in the 
side chain oxidation, as a result of which C27 bile acids, and 
surprisingly C29 bile acids (for unknown reasons), accumu-
late2. Improvements have been noted when patients were 
treated with a mixture of cholic and chenodeoxycholic acids.  
 It has been noticed that bile acids play a significant role 
in the etiology of intestinal cancer23. Studies have indicated 
that certain dietary habits affect bile acid metabolism in a 
way that may have a role in carcinogenesis. It has also been
shown that the ingestion of large amounts of fats, particu-
larly of animal origin, is an important element responsible 
for intestinal cancer. Earlier, cholic and deoxycholic acids 
were considered to act as mutagens or co-carcinogens24. 
Recently, several epidemiological studies have indicated 
that the possible mechanism of action is bile acid-induced 
DNA binding and transactivation of activator protein-1 
(AP-1) by cooperative activation of extracellular signal-
regulated kinases (ERKs) and protein kinase C (PKC) 
signalling25. Therefore, bile acids are now considered to act 
as tumour promoters, and not as mutagens.  
 Gallstones are formed by the accumulation of cholester l, 
bilirubin and calcium carbonate in the gall bladder. Chole-
sterol gallstones are preponderantly found compared to 
other types of gallstones. The aqueous solubility of chole-
sterol in bile principally depends on the formation of mixed 
micelles by biliary bile salts and phospholipids. Thus, either 
an increased concentration of cholesterol or a reduced 
concentration of bile salts would result in the precipitation 
of cholesterol as gallstone26. It has been observed that 
gallstone patients have both increased cholesterol synthe is 
and reduced conversion of cholesterol to bile acids. Che-
nodeoxycholic acid has been used as a gallstone-dissolving 
agent for quite some time. However, during the last decade, 
ursodeoxycholic acid has become most useful for non-sur-
gical treatment for gallstone diseases because of its rduced 
cytotoxic ty27.  
Pharmacological applications of bile acid  
analogues 
During the last few decades, there has been considerable 
inte est in the synthesis and study of cationic surfactants 
fr m bile derivatives28. In most of these studies, a diamine 
is attached to the bile acid through an amide bond, and the 
other amine is converted to a quaternary ammonium salt. 
Fini nd coworkers29 reported comparative studies between 
the acid and basic derivatives. Bernheim and Lack30 studied 
a series of cholanic-acid derivatives, and showed that the 
cationic bile salts (Figure 5) are potent in accelerating bac-
terial swelling30. In addition to bacterial swelling (which 
even he anionic ones accomplish), these are shown to inhibit 
protein synthesis. Antiviral31 and antifungal32 properties 
f some bile acid derivatives have been evaluated. Quater-
nary ammonium salts derived from bile acids (Figure 6) 
act as cholesterol dissolution agents33. The e steroid deri-
vatives are known to accelerate the dissolution of choles-
REVIEW ARTICLES 
 
CURRENT SCIENCE, VOL. 87, NO. 12, 5 DECEMBER 2004 1673 
 
 
Figure 6. Kwan’s cholesterol solubilizing accelerators. 
 
 
 
 
Figure 7. DNA transfecting agent. 
 
 
terol monohydrate pellets in synthetic bile (11 mM NaC–
32 mM lecithin), even at relatively low concentrations. 
Nor- and homo-bile acid derivatives have been added to 
some medicaments in order to improve their absorpt on34. 
Cationic amphi hiles derived from bile acids conjugated 
with polyamines were shown to dramatically incre se the 
cellular uptake of DNA35. The transfection activity of bile 
acid conjugated polyamines (Figure 7) in combination with 
dioleoyl phosphatidyl-ethanolamine (DOPE) ranged three 
to seven times the optimal activity of lipofectin (DOTMA 
(N-[1,2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium 
chloride) + DOPE), the first cationic lipid based gene deli-
very agent. Efficient calf thymus DNA condensation upon 
binding with bile acid polyamine ad s has also been re-
ported36.  
 It has recently been realized that the high specificity and 
capacity of bile acid transport systems during their ente-
rohepatic circulation might form the basis of current res-
earch on drug–bile acid conjugates for specific drug 
targetting to the liver and for improving the intestinal absor-
ption of poorly absorbed or non-absorbed drugs, such as 
peptides37.  
Micelle formation in aqueous solutions 
In aqueous environments, bile salts aggregate to form mi-
celles38. These micelles, under physiological conditions, 
are transformed into mixed-micelles (see later in the article) 
with lecithin and glycerides, which are responsible for fat/ 
cholesterol solubilization in the small intestine. The 
physical chemistry of micellization of bile salts has been, 
and still is, an active area of research. A variety of state-
of-the-art techniques have been employed in order to gain 
more insights into the sructure/size/shape of bile-salt mi-
celles. This section will deal with both concepts and tech-
niques (classical and advanced) used to unders and structure 
and dynamics of bile-salt micelles.  
 Unlike conventional surfactant molecules, bile salts 
possess a rigid steroid backbone having polar hydroxyl 
groups on the concave a-face and methyl groups on the 
convex b-face (Figure 2). This arrangement creates a 
unique facial amphiphilicity for this class of molecules, 
enabling them to aggregate in aqueous media in a manner 
different from conventional detergents. Aggregation of 
bile salts in aqueous solution is largely driven by the hy-
drophobic association of apolar b-f ces of steroid back-
bones, while further aggregation occurs through hydrogen 
bonding interactions (Figure 8). Critical micellar concen-
trations (CMCs) of dihydroxy bile salts are typically below 
5 mM, whereas trihydroxy bile salts have higher CMC1 
ranging from 10 to 15 mM. The higher CM  of trihydroxy 
bile salts is attributed to their higher solubility in water. 
The aggregation number of these bile-salt mcelles ranges 
from 2 to 10 for globular primary aggregates, which in-
creases as a function of the bile-salt concentration (and 
added salt concentration) to form larger secondary aggre-
gates. These have been suggested to be rod-like by small-
angle X-ray scattering (SAXS) and small-ang e neutron 
scattering (SANX) studies38. A model for the primary and 
the secondary aggregation was first propo ed by Small 
(Figure 8)38. The aggregation number of several bile salts 
(free and conjugated) was determined by ultracentrifuga-
tion and quasi-elastic light scattering (QLS) techniques. 
Trihydroxy bile salt (sodium cholate) in pure water forms 
smaller micelles (with aggregation number 2). The aggre-
gation number increases with increasing added salt (NaCl). 
Increase in the aggregation number is more pronounced 
in the case of dihydroxy bile salts (deoxycholic acid and 
chenodeoxycholic acid). A lowering of pH ( rom 9 to 7.3) 
further increases the aggregation number (>500) for dihy-
droxy bile salts, which is responsible for thickening of the 
aqueous solution to afford gel or gel-like materials39.  
 QLS-studies have suggested that the hydrodynamic ra ius 
increases from 10 to 16 Å for smaller primary micelles to 
about 100 Å for larger secondary micelles. It was also 
found that the bile salt micelles are polydisperse  (~20 
and ~50% for small and large micelles respectively)38,40. 
 We have recently described a convenie t way to deter-
mine the average micellar size by monitoring the rotational 
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Figure 8. Cartoon representations of bile salt micelles (primary and secondary aggregation 
model) as introduced by Small. 
 
 
diffusion (by pico-second time-r solved fluorescence aniso-
tropy decay) using fluorescent probes (DPH: 1,6-diphenyl-
1,3,5-hexatriene and ANS: 1-anilinonaphthalene-8-sulphonic 
acid) complexed to bile salt micelles. DPH showed a singl  
rotational correlation time (about 2 ns in sodium cholate 
and 3.5 ns in sodium deoxycholate micell s)41. The DPH–
bile-salt micelle system was the first one to show a single 
rotational correlation time (j) among all other micelle-
probe combinations42. This is due to the fact that nonpolar 
DPH intercalates tightly to the micellar interior of a bile-
salt. Thus the observed rotational dynamics reports the 
global micellar tumbling of the bile-salt micelle. Thus the 
Stokes–Einstein equation, j =hV/kT (h is viscosity and V 
is hydrodynamic volume)42 can be used to determine the 
average size of bile-salt micelles. The rotational correlati n 
time of DPH in sodium deoxycholate micelle incr ased 
from 3.5 (no salt) to 7.5 ns in the presence of 0.3 M NaCl43, 
due to increase in micellar size (aggregation number) with 
added salt12. Interestingly, a partly water-soluble probe such 
as ANS showed two rotational correlation times, which 
could be due to the distribution of amphiphilic dye in the 
hydrophobic phase and in the aqueous phase (possibly 
micelle–water interface). This probe may be useful to un-
cover finer details of the interfacial water molecules in 
bile-salt micelles. Similar results were obtained when cou-
marin 480 was used to probe the dynamics of bile-salt 
micelle44. In mixed micelles (bile salt–Triton X 100 and 
bile salt–CTAB), the slower dynamics may arise due to 
increase in size and microviscosity.  
 Solvation dynamics of a few fluorescent probes in bile-salt 
micelles has also been determined using time-resolved 
emission spectra (TRES)45. Usually the solvation time (re-
orientation time of solvent molecules in response to the 
instantaneously created dipole by excitation) in bulk water 
is very fast (<1 ps), whereas in organized assemblies (like 
membrane, micelles, etc.), it is (ultra) slow and complex46.
Interpretation of TRES data is not always straightforw rd 
i  complex systems47. However, the average solvation time 
ranges from 1 to 2 ns in bile salt micelle48. The substantially 
slow solvation dynamics of water in the vicinity of sod um
deoxycholate micelle arises from trapped water molcules 
(bound to the hydroxyl groups, carboxylates and sodium 
ions). Extension of this work to bile salt–Triton X and bile 
salt–CTAB mixed micelle using coumarin 480 as a fluore-
scent dye also revealed slow solvation dynamics in the 
Stern layer of the mixed micelles44. The above study shows 
the presence of strongly bound water molecules in the 
bile-salt micellar surface.  
Mixed micelle formation 
Emulsification of fat through mixed micelle formation is 
one of the significant prope ties of bile salts. Bile acids 
perform almost all physiological functions (discussed ear-
lier) in the form of mixed-micelles. Bile-salt micelles can 
solubilize cholesterol, lecithin, monoglycerides, etc., which 
are intrinsically water-insoluble49. The aqueous solubility 
of cholesterol (~1 nM) can increase more than a million 
fold in the presence of bile-salt micelles50. The cholesterol 
solubilization ability is far better with dihydroxy bile-salts 
than with trihydroxy bile-sa ts. It further increases in the 
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Figure 9. Proposed molecular arrangements of bile salt–lecithin–cholesterol mixed micelles. a, Longitudinal 
view; b, Cross-sectional view. 
 
 
presence of lecithin because of the formation of mixed 
micelles (Figure 9). The average size of mixed micell s is 
much larger compared to pure bile-salt micelles, and the 
hydrodynamic radius can go up to several nanometres50. 
In addition to their physiological roles, bile-salt mixed-
micelles are promising systems for drug delivery. The 
solubilization of drugs by bile-salt micelles (through the 
formation of mixed-micelles) has been examined50. 
Supramolecular chemistry of bile acids 
This section deals with relatively newer aspects (supra-
molecular chemistry and molecular recognition) of bile 
acids. Because of the unique structural elements, bile acids 
constitute one of the most prominent classes in the study 
of molecular recognition, host–guest chemistry, biomimetic 
chemistry, etc51. Some of the bile acids and their analo-
gues act as potent gelators (gel-forming agents) in both 
organic and aqueous media. These gels may hold promise 
for future biomaterials.  
Molecular recognition and biomimetic chemistry 
The bile acid skeleton plays an important role as a chiral 
building block to construct artificial receptors and supra-
molecular architectures. Cholic acid is a convenient build-
ing block for biomimetic systems because of the following 
f atures: (i) rigidity of the steroid 5b-framework (cis A/B 
ring fusion) ensures the formation of a cavity; (ii) the two 
faces of the steroid differ dramatically in their properties – 
the a-face displays three hydrogen-bonding groups, while 
the b-face is entirely hydrophobic; (iii) the hydroxyl groups 
are directed toward the centre of the concave face; (iv) the 
side-chain carboxylate can be readily derivatized, and (v) 
it is chiral. The crystal structure of bile-acid derivatives often 
shows the presence of channels with guest or solvent 
molecules (Figure 10)52. The tendency to form channels 
in the solid state arises as a result of the facially amphi illic 
nature of bile acids. In solution, bile acids and their conju-
gates have been utilized to solubilize nonpolar substance  
in water53. Burrows and co-workers54 used dimeric bile acid 
derivatives for binding monosaccharides and DNA. A variety 
of macrocyclic bile acids known as cholaphanes were 
shown to bind diverse types of guests. Diastereo- and nantio-
selective binding of octylglucosides by a tetrahydroxychol-
aphane has been reported55. Davis and co-workers56 reported 
cholaphanes that bind alkyl glucosides and anions, depe -
ding on the size of the cavity. A new generation of chola-
phanes (Figure 11) with externally directed alkyl chains 
(for solubility in organic solvents) was synthesized and shown 
to form a 1 :  complex with a b-D-glucoside with a mode-
a 
b 
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Figure 10. Arrangements of sodium cholate molecules in solid state. a, Packing of two sodium cholate molecules. b, Expanded view 
showing hydrogen-bonding interactions with solvent molecules.  
 
 
 
 
Figure 11. Cholaphane: A receptor of carbohydrate nuclei. 
 
 
 
Figure 12. Acyclic cholic acid-based receptor for anions. 
 
Figure 13. Bile acid-based macrocycles for biomimetic recognition. 
 
Figure 14. Cholic acid-based triply-bridged cholaphane. 
a b 
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rately high association constant in CDCl3. It was also 
possible to demonstrate the extraction of b-D-glucoside to 
an organic layer from aqueous solutions.  
 The selective binding of fluoride ion by an acyclic cholic 
acid-based receptor was demonstrated by Davis andcowor-
kers (Figure 12)57. Bile acid-based macrocycles of varying 
sizes (Y is variable spacer) and flexibility were synthesized 
(Figure 13)58. Cholic acid-based triply-bridged cyclophane 
(Figure 14)59 possesses a hydrophilic cavity and can recog- 
 
 
 
 
Figure 15. MEM-protected cholaphane. 
 
 
 
 
Figure 16. Porphyrin conjugated cyclocholates. 
nize hydrophilic hosts in organic solvents. It was shown that 
such molecules bind nitrophenols, triethanolamine, amino 
acids and octyl-glucosides.  
 Bonar-Law and Sanders60 reported a bile acid-based iono-
phore having a MEM-protected cholaphane, which was 
found to bind alkali metal ions (Figure 15). This group also 
designed and synthesized a range of porphyrin-c njugated 
cyclocholates such as porphyrin-capped cyclocholates61 
and porphyrin bowls (Figure 16)62.  
 A novel artificial ion channel consisting of a macrocyclic 
cholic-acid derivative (Figure 17) was synthesized by Yo-
shino et al.63 Two- and four-walled molecular umbrellas 
based on cholic acid have been synthesized (Figure 18), 
which are able to transport hydrophilic molecules (pepti-
des, thiolated AMP and ATP) across liposomal membranes64.  
 From our laboratory the utility of bile acids is in the con-
struction of macrocycles (Figure 19 a)65, receptors for 
adenine/biotin (Figure 19 b)66, dentritic specis (Figure 
20)67 and alkali metal ions (Figure 19 c)68. Semi-rigid mole-
cular tweezers for electron-deficient aromatic comp unds 
were built by appending aromatic surfaces on the rigid bile 
acid scaffold (Figure 21)69. Recently, bile acid-based 
dendrons were synthesized from 2,2-bis(hydroxymethyl) 
propionic acid (bis-MPA) and lithocholic acid by a conver-
gent method70. These molecules hold promise as potential 
drug carriers.  
Supramolecular association leading to gelation of 
organic fluids 
Miyata and co-workers71 reported that N-isopropylamide 
of cholic acid (Figure 22) is an efficient gelator of aromatic 
solvents in the presence of methanol. Transmission electron 
microscopic (TEM) studies of the gel showed the presenc 
of fibres of ca. 200 nm diameter. It was serendipitously 
discovered by us that a bile-acid derivative with a pyrene  
 
 
 
 
Figure 17. Cholic acid based artificial ion channel. 
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Figure 18. Tetra-walled molecular umbrella derived from cholic acid. 
 
 
 
 
Figure 19. Bile acid-based macrocycle (a), receptor for adenin/biotin (b), receptor for alkali metal ions (c). 
 
 
moiety attached to C-3 through an ester linkage (Figure 
23), formed stable gels in the presence of trinitrofluorenone 
(TNF) in a mixture of chloroform and ethanol. These gels 
were coloured due to the charge-tr nsfer interaction bet-
ween the electron- ich pyrene unit and electron deficient 
TNF72. 
 Recently, a number of N-cholyl amino acid alkyl esters 
(Figure 24) were shown to form stable organogels in aro-
matic solvents and in cyclohexane73. Hydrogen-bonding 
interactions were reported to be responsible for the self-
assembly leading to gelation. The chiral centre of the amino 
acid component seems to play an important role in gelati n.  
Supramolecular association leading to hydrogelation 
It was mentioned earlier that under certain defined condi-
tions bile acids/salts form gels in water. This unusual beha-
viour of bile acids was known for a long time74. Sodium 
cholate, sodium deoxycholate and sodium lithocholate 
w re shown to form gels in water. The gelation was found
to be pH-dependent (optimal at pH ~ 7), and the gels were 
thixotropic in nature. However, some of these interesting 
observations remained unnoticed by several researche s 
in this area75. X-ray diffraction studies performed by Rich 
and Bl w on the deoxycholate gel revealed that the (supr ) 
molecular complex formed a helical structure with 36 Å 
diameter. The complex formation (gelation) was favoured 
at lower pH and higher ionic strength12. 
From our laboratory we have demonstrated efficient 
gelation of predominantly aqueous fluids by a cholic acid 
trimer (tripodal cholamide, Figure 25)76. These gels were 
transparent (Figure 26 a), and formed at remarkably low 
gelator concentrations (0.02% w/v, 0.15 mM, i.e. one gelator 
molecule immobilizing >105 water molecules). A cryo-
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Figure 20. Bile acid based dendrimer. 
 
 
 
Figure 21. Molecular tweezers based on bile acids. 
 
 
Figure 22. Cholic acid-based organogelator. 
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Figure 23. Bile acid-based organogelators. 
 
 
 
 
Figure 24. N-cholyl amino acid alkyl esters as organogelators. R1, 
Amino acid side chain; R2, Alkyl groups.  
 
 
 
 
Figure 25. Tripodal cholamide gelator. 
 
 
 
TEM image of the gel showed the presence of nanofibres 
(Figure 27). The formation of hydrophobic ‘pockets’ during 
gelation was inferred using ANS as a polarity-sens ive 
probe. ANS became highly fluorescent in the gel state 
(Figure 26 b). A thermochromic gel was developed using 
bromophenol blue as a dye. The rotational dynamics of 
polarity-sensitive fluorescent dyes (ANS and DPH) in an 
aqueous gel derived from tripodal cholamide 1 was studied 
using picosecond time-resolved fluorescence technique15.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANS in the gel showed two rotational correlation time (j) 
components, ca. 13 ns (ANS bound to the hydrophobic 
region of the gel) and ca. 1ns (free aqueous ANS); whereas 
DPH showed only one component (ca. 5 ns) characteristic 
of a single population of the dye in the hydrophobic pockets 
of the gel. The second shorter component for ANS may be 
due to its partitioning into the aqueous phase of the gel-net-
work. It is interesting to no ice about ten-fold dampening 
(j ~ 1 ns) of the dynamics in the aqueous phase of the gel 
 
 
Figure 26. Photograph of gels from tripodal cholamide (5 mM in 
20% AcOH–water) in the presence of 30mM ANS. a, Transparent gel, 
and b, Luminescent gel. 
b a 
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network compared to ANS in water (~0.1 ns). This obser-
vation is attributed to partial immobilization of water mole-
cules around the nanofibres of the gel, which increases the 
microviscosity of the aqueous phase experienced by ANS. 
These gels could act as excellent materials for future appli-
cations because of their remarkable water-holding ability 
and efficient dye-solubilization property. However, we have 
demonstrated an application of one of these gels (compo-
sed of networked fibre of nanometric dimension) in creating 
 
 
 
 
Figure 27. Cryo-TEM image of gel derived from tripodal cholamide. 
 
 
 
 
 
Figure 28. Titania nanotubes made from hydrogel derived from tri-
podal cholamide gelator (Figure 25). 
 
 
Figure 29. Cationic and neutral analogues of bile acids. 
 
 
 
 
Figure 30. Phosphonobile acids. 
 
 
inorganic nanostructures. The gel derived from tripodal 
cholamide was used as an organic template to prepare inor-
ganic nanotubes by employing sol-gel template technique 
(Figure 28)77.  
 Simpler monomeric cationic and neutral analogues of 
bile acids were also synthesized and evaluated for gelation. 
It was found that several cationic dihydroxy bile salt ana-
logues form gels in aqueous fluids (Figure 29)78. Gelation 
behaviour of phosphonobile acids (where CO2H of the 
steroid is replaced by a PO3H2; Figure 30) in acidic pH has 
also been observed recently79. Potential biological appli-
cations of these monomeric cationic and anionic bile acid 
analogues are currently being evaluated in our laboratory. 
Concluding remarks 
This review encompasses several classical nd emerging 
aspects of chemistry and biology of bile acids. We have 
described the utility of bile acids both in physiology and 
in structural chemistry. The diverse and unique properties 
pertaining to both chemistry and biology arise from their 
structural uniqueness. The facial amphiphilicity w th rigid 
steroid backbone seems to be most important in the expre-
ssion of their chemical/supramolecular/biological/physio-
l gical properties. Additionally, hydrogels derived from 
bile acids are of considerabl  interest due to their excellent 
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water-holding ability. Dye-intercalation studies on gels 
show that they could be potential materials for small 
molecule (drug) delivery. It is noteworthy that these hy-
drogels are thermoreversible and biodegradable, unlike 
traditional polymeric gels. It remains to be seen whether 
these bile acid-based artificial receptor/surfactant/gelator 
molecules are promising candidates for pharmacological 
applications. We believe that the information contained in 
this article will be useful to develop various bile acid 
based molecular and supramolecular systems with widely 
different goals.  
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